{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,388.95",
    "chg": 385.05,
    "chgp": "4.81%",
    "dir": 1,
    "prev_price": "8,003.90",
    "mcapval": "20,972.38 Cr",
    "mcap": "Large Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE203A01020",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:27 AM",
    "bse_nse_vol": "18.23 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/1",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Astrazeneca Pharma India Faces Short-Term Challenges Amid Strong Long-Term Growth Potential",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-stock-declines-5-26-total-drop-of-10-65-over-three-days-1694742",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/AstrazenecaPhar_priceRelatedfactors_884485.png",
        "date": "2025-04-03 10:20:21",
        "description": "Astrazeneca Pharma India faced a decline on April 3, 2025, amid a tough market, marking a three-day drop of 10.65%. Despite recent challenges, the stock has shown strong long-term performance, with significant gains over the past month, year, and multi-year periods, indicating a solid industry position."
      },
      {
        "title": "Astrazeneca Pharma India Faces Short-Term Decline Amid Strong Long-Term Growth Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-declines-3-3-amidst-recent-stock-losses-1676094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/AstrazenecaPhar_priceRelatedfactors_869897.png",
        "date": "2025-04-02 12:35:19",
        "description": "Astrazeneca Pharma India has faced a recent decline, with consecutive losses leading to a notable drop. However, the stock has demonstrated strong long-term performance, surging significantly over the past month and year. Its moving averages indicate a mixed short-term trend amidst its robust standing in the pharmaceuticals sector."
      },
      {
        "title": "Astrazeneca Pharma India Achieves 52-Week High Amid Strong Financial Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-achieves-52-week-high-of-rs-9049-95-with-12-25-growth-1573482",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AstrazenecaPhar_priceRelatedfactors_771226.png",
        "date": "2025-03-24 09:40:59",
        "description": "Astrazeneca Pharma India has achieved a new 52-week high stock price, reflecting strong performance with significant gains over recent days. The company reported robust quarterly results, high return on equity, and a low debt-to-equity ratio, reinforcing its position as a leading player in the pharmaceuticals sector."
      },
      {
        "title": "Astrazeneca Pharma India Achieves Record High Amid Strong Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-achieves-all-time-high-stock-price-of-rs-9049-95-1573333",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AstrazenecaPhar_priceRelatedfactors_771104.png",
        "date": "2025-03-24 09:35:21",
        "description": "Astrazeneca Pharma India has achieved a new all-time high, reflecting strong momentum with a notable performance over recent days. The stock has consistently outperformed its sector and is trading above key moving averages, showcasing impressive returns over various time frames and solidifying its position in the pharmaceuticals sector."
      },
      {
        "title": "Astrazeneca Pharma India Achieves All-Time High Stock Price Amid Strong Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-achieves-all-time-high-of-rs-9049-95-today-1573203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AstrazenecaPhar_priceRelatedfactors_770967.png",
        "date": "2025-03-24 09:31:47",
        "description": "Astrazeneca Pharma India has achieved an all-time high stock price of Rs. 9049.95, reflecting strong performance with a 72.86% return over the past year. The company reported record net sales of Rs. 440.29 crore and maintains a solid operating profit margin, showcasing effective management and market positioning."
      },
      {
        "title": "Astrazeneca Pharma India Achieves All-Time High Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-achieves-4-94-gain-reaches-all-time-high-of-rs-8310-15-1503067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AstrazenecaPhar_priceRelatedfactors_732275.png",
        "date": "2025-03-20 12:05:20",
        "description": "Astrazeneca Pharma India has achieved a new all-time high, reflecting its strong market position in the pharmaceuticals sector. The stock has consistently outperformed benchmarks, showing significant gains over the past month and year, while maintaining a solid upward trend across various moving averages."
      },
      {
        "title": "Astrazeneca Pharma India Achieves 52-Week High Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-achieves-52-week-high-with-63-58-annual-return-1503063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AstrazenecaPhar_priceRelatedfactors_732277.png",
        "date": "2025-03-20 12:05:19",
        "description": "Astrazeneca Pharma India has achieved a new 52-week high stock price, reflecting strong market performance amid a positive trend. The company reported impressive financial metrics, including significant annual returns and robust quarterly growth, while maintaining a solid financial foundation and high management efficiency, reinforcing its industry reputation."
      },
      {
        "title": "Astrazeneca Pharma India Stock Reaches All-Time High, Signaling Strong Market Confidence",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-reaches-all-time-high-stock-price-of-rs-8090-35-1502495",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AstrazenecaPhar_priceRelatedfactors_731535.png",
        "date": "2025-03-20 11:51:13",
        "description": "Astrazeneca Pharma India has achieved an all-time high stock price, reflecting strong performance in the pharmaceuticals sector. The company has outperformed the broader market significantly, with impressive gains over the past month and year. Its robust management efficiency and consistent growth further underscore its strong market position."
      },
      {
        "title": "AstraZeneca Pharma India Shows Mixed Technical Trends Amid Strong Performance Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-indias-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-strong-performance-1214074",
        "imagepath": "",
        "date": "2025-03-06 08:01:50",
        "description": "AstraZeneca Pharma India, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 7,354.35, showing a notable increase from the previous close of 7,262.10. Over the past week, AstraZeneca has demonstrated a strong performance, achieving a return of 6.66%, significantly outperforming the Sensex, which recorded a decline of 1.17%.\n\nThe company's technical indicators present a mixed picture. The MACD shows bullish momentum on a weekly basis, while the monthly perspective leans mildly bearish. Additionally, the Bollinger Bands and On-Balance Volume (OBV) indicators are bullish on both weekly and monthly charts, suggesting positive market sentiment. However, the Dow Theory indicates a mildly bearish trend on a weekly basis, contrasting with a mildly bullish monthly outlook.\n\nIn terms of histori..."
      }
    ],
    "total": 58,
    "sid": "777011",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015",
      "datetime": "04-Apr-2025",
      "details": "Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-Apr-2025",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015",
      "datetime": "28-Mar-2025",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1200%</strong> dividend, ex-date: 05 Jul 24",
          "dt": "2024-07-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astrazeneca Pharma India Faces Short-Term Challenges Amid Strong Long-Term Growth Potential

2025-04-03 10:20:21

Astrazeneca Pharma India faced a decline on April 3, 2025, amid a tough market, marking a three-day drop of 10.65%. Despite recent challenges, the stock has shown strong long-term performance, with significant gains over the past month, year, and multi-year periods, indicating a solid industry position.

Read More

Astrazeneca Pharma India Faces Short-Term Decline Amid Strong Long-Term Growth Trends

2025-04-02 12:35:19

Astrazeneca Pharma India has faced a recent decline, with consecutive losses leading to a notable drop. However, the stock has demonstrated strong long-term performance, surging significantly over the past month and year. Its moving averages indicate a mixed short-term trend amidst its robust standing in the pharmaceuticals sector.

Read More

Astrazeneca Pharma India Achieves 52-Week High Amid Strong Financial Performance

2025-03-24 09:40:59

Astrazeneca Pharma India has achieved a new 52-week high stock price, reflecting strong performance with significant gains over recent days. The company reported robust quarterly results, high return on equity, and a low debt-to-equity ratio, reinforcing its position as a leading player in the pharmaceuticals sector.

Read More

Astrazeneca Pharma India Achieves Record High Amid Strong Market Sentiment

2025-03-24 09:35:21

Astrazeneca Pharma India has achieved a new all-time high, reflecting strong momentum with a notable performance over recent days. The stock has consistently outperformed its sector and is trading above key moving averages, showcasing impressive returns over various time frames and solidifying its position in the pharmaceuticals sector.

Read More

Astrazeneca Pharma India Achieves All-Time High Stock Price Amid Strong Performance

2025-03-24 09:31:47

Astrazeneca Pharma India has achieved an all-time high stock price of Rs. 9049.95, reflecting strong performance with a 72.86% return over the past year. The company reported record net sales of Rs. 440.29 crore and maintains a solid operating profit margin, showcasing effective management and market positioning.

Read More

Astrazeneca Pharma India Achieves All-Time High Amid Strong Market Performance

2025-03-20 12:05:20

Astrazeneca Pharma India has achieved a new all-time high, reflecting its strong market position in the pharmaceuticals sector. The stock has consistently outperformed benchmarks, showing significant gains over the past month and year, while maintaining a solid upward trend across various moving averages.

Read More

Astrazeneca Pharma India Achieves 52-Week High Amid Strong Market Performance

2025-03-20 12:05:19

Astrazeneca Pharma India has achieved a new 52-week high stock price, reflecting strong market performance amid a positive trend. The company reported impressive financial metrics, including significant annual returns and robust quarterly growth, while maintaining a solid financial foundation and high management efficiency, reinforcing its industry reputation.

Read More

Astrazeneca Pharma India Stock Reaches All-Time High, Signaling Strong Market Confidence

2025-03-20 11:51:13

Astrazeneca Pharma India has achieved an all-time high stock price, reflecting strong performance in the pharmaceuticals sector. The company has outperformed the broader market significantly, with impressive gains over the past month and year. Its robust management efficiency and consistent growth further underscore its strong market position.

Read More

AstraZeneca Pharma India Shows Mixed Technical Trends Amid Strong Performance Surge

2025-03-06 08:01:50

AstraZeneca Pharma India, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 7,354.35, showing a notable increase from the previous close of 7,262.10. Over the past week, AstraZeneca has demonstrated a strong performance, achieving a return of 6.66%, significantly outperforming the Sensex, which recorded a decline of 1.17%. The company's technical indicators present a mixed picture. The MACD shows bullish momentum on a weekly basis, while the monthly perspective leans mildly bearish. Additionally, the Bollinger Bands and On-Balance Volume (OBV) indicators are bullish on both weekly and monthly charts, suggesting positive market sentiment. However, the Dow Theory indicates a mildly bearish trend on a weekly basis, contrasting with a mildly bullish monthly outlook. In terms of histori...

Read More

View All News